AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.290
+0.020 (1.57%)
Apr 24, 2025, 4:00 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $38.83 million as of April 24, 2025. Its market cap has decreased by -56.67% in one year.
Market Cap
38.83M
Enterprise Value
-45.39M
1-Year Change
-56.67%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $38.83M, a decrease of -86.19%. That is a compound annual growth rate of -47.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 38.23M | -7.29% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.44B |
| AbbVie | 313.20B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |